X-ray and NMR characterization of covalent complexes of trypsin, borate, and alcohols

被引:52
作者
Transue, TR [1 ]
Krahn, JM [1 ]
Gabel, SA [1 ]
DeRose, EF [1 ]
London, RE [1 ]
机构
[1] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1021/bi035782y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An understanding of the physiological and toxicological properties of borate and the utilization of boronic acids in drug development require a basic understanding of borate-enzyme chemistry. We report here the extension of our recent NMR studies indicating the formation of a ternary borate-alcohol-trypsin complex. Crystallographic and solution state NMR studies of porcine trypsin were performed in the presence of borate and either of three alcohols designed to bind to the S1 affinity subsite: 4-aminobutanol, guanidine-3-propanol, and 4-hydroxymethylbenzamidine. Quaternary complexes of trypsin, borate, SI-binding alcohol, and ethylene glycol (a cryoprotectant), as well as a ternary trypsin, borate, and ethylene glycol complex have been observed in the crystalline state. Borate forms ester bonds to Ser195, ethylene glycol (two bonds), and the SI-binding alcohol (if present). Spectra from (1)H and (11)B NMR studies confirm that these complexes also exist in solution and also provide evidence for the formation of ternary trypsin, borate, and S1-subsite alcohol complexes which are not observed in the crystals using our experimental protocols. Analysis of eight crystal structures indicates that formation of an active site borate complex is in all cases accompanied by a significant (similar to4%) increase in the b-axis dimension of the unit cell. Presumably, our inability to observe the ternary complexes in the crystalline state arises from the lower stability of these complexes and consequent inability to overcome the constraints imposed by the lattice contacts. A mechanism for the coupling of the lattice contacts with the active site that involves a conformational rearrangement of Gln192 is suggested. The structures presented here represent the first crystallographic demonstration of covalent binding of an enzyme by borate.
引用
收藏
页码:2829 / 2839
页数:11
相关论文
共 57 条
[1]  
ANTONOV VK, 1970, FEBS LETT, V16, P23
[2]   Structural biology of C1 [J].
Arlaud, GJ ;
Gaboriaud, C ;
Thielens, NM ;
Rossi, V .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 :1001-1006
[3]   DYNAMICS OF BORON ACID COMPLEXATION REACTIONS - FORMATION OF 1-1 BORON ACID LIGAND COMPLEXES [J].
BABCOCK, L ;
PIZER, R .
INORGANIC CHEMISTRY, 1980, 19 (01) :56-61
[4]   Molecular recognition of protein-ligand complexes: Applications to drug design [J].
Babine, RE ;
Bender, SL .
CHEMICAL REVIEWS, 1997, 97 (05) :1359-1472
[5]   N-15 NMR-SPECTROSCOPY OF THE CATALYTIC-TRIAD HISTIDINE OF A SERINE PROTEASE IN PEPTIDE BORONIC ACID INHIBITOR COMPLEXES [J].
BACHOVCHIN, WW ;
WONG, WYL ;
FARRJONES, S ;
SHENVI, AB ;
KETTNER, CA .
BIOCHEMISTRY, 1988, 27 (20) :7689-7697
[6]   Inhibition of Mn-2(2+)-arginase by borate leads to the design of a transition state analogue inhibitor, 2(S)-amino-6-boronohexanoic acid [J].
Baggio, R ;
Elbaum, D ;
Kanyo, ZF ;
Carroll, PJ ;
Cavalli, RC ;
Ash, DE ;
Christianson, DW .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (34) :8107-8108
[7]   Crystal structure of the NADP(H)-dependent ketose reductase from Bemisia argentifolii at 2.3 Å resolution [J].
Banfield, MJ ;
Salvucci, ME ;
Baker, EN ;
Smith, CA .
JOURNAL OF MOLECULAR BIOLOGY, 2001, 306 (02) :239-250
[8]   Inhibition of SERCA Ca2+ pumps by 2-aminoethoxydiphenyl borate (2-APB) -: 2-APB reduces both Ca2+ binding and phosphoryl transfer from ATP, by interfering with the pathway leading to the Ca2+-binding sites [J].
Bilmen, JG ;
Wootton, LL ;
Godfrey, RE ;
Smart, OS ;
Michelangeli, F .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (15) :3678-3687
[9]   High-throughput crystallography for lead discovery in drug design [J].
Blundell, TL ;
Jhoti, H ;
Abell, C .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (01) :45-54
[10]   High-throughput X-ray crystallography for drug discovery [J].
Blundell, TL ;
Abell, C ;
Cleasby, A ;
Hartshorn, MJ ;
Tickle, IJ ;
Parasini, E ;
Jhoti, H .
DRUG DESIGN: CUTTING EDGE APPROACHES, 2002, (279) :53-59